{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:50:08Z","timestamp":1784062208208,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Western Australia Department of Health"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.vaccine.2016.05.015","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T14:04:39Z","timestamp":1463493879000},"page":"3350-3355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Continuous active surveillance of adverse events following immunisation using SMS technology"],"prefix":"10.1016","volume":"34","author":[{"given":"Darren W.","family":"Westphal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Leeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"Effler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.05.015_bib0110","series-title":"Promoting safety of medicines in children","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0115","series-title":"Mann's pharmacovigilance","article-title":"Vaccine safety surveillance","author":"Woo","year":"2014"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0120","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0125","first-page":"3","article-title":"Mumps and mumps vaccine: a global review","volume":"77","author":"Galazka","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0130","doi-asserted-by":"crossref","first-page":"e000016","DOI":"10.1136\/bmjopen-2010-000016","article-title":"Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine","volume":"1","author":"Armstrong","year":"2011","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00128072-200002040-00004","article-title":"Safety of routine childhood vaccinations. An epidemiological review","volume":"2","author":"Chen","year":"2000","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0140","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) \u2013 United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"Morb Mortal Wkly Rep Surveill Summ"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0145","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.2010.tb04029.x","article-title":"Febrile convulsions after 2010 seasonal trivalent influenza vaccine: implications for vaccine safety surveillance in Australia","volume":"193","author":"Gold","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0150","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.ede.0000155506.05636.a4","article-title":"Active surveillance of vaccine safety: a system to detect early signs of adverse events","volume":"16","author":"Davis","year":"2005","journal-title":"Epidemiology"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.05.015_bib0155","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1542\/peds.2010-1722I","article-title":"Active surveillance for adverse events: the experience of the Vaccine Safety Datalink project","volume":"127","author":"Yih","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0160","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5694\/mja13.11166","article-title":"Using automated text messages to monitor adverse events following immunisation in general practice","volume":"200","author":"Leeb","year":"2014","journal-title":"Med J Aust"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0165","series-title":"The Australian Immunisation Handbook: 10th edition 2013 (updated January 2014)","author":"Australian Technical Advisory Group on Immunisation","year":"2014"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0170","first-page":"294","article-title":"Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria","volume":"35","author":"Clothier","year":"2011","journal-title":"Commun Dis Intell Q Rep"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0175","first-page":"S9","article-title":"Routine vaccines across the life span, 2005","volume":"54","author":"Zimmerman","year":"2005","journal-title":"J Fam Pract"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0180","series-title":"Western Australia Vaccine Safety Surveillance \u2013 annual report, 2014","author":"Prevention and Control Program CDCD, Western Australia Department of Health","year":"2014"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0185","first-page":"CD001478","article-title":"Acellular vaccines for preventing whooping cough in children","volume":"9","author":"Zhang","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0190","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1542\/peds.112.6.e453","article-title":"Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact","volume":"112","author":"Skowronski","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0195","doi-asserted-by":"crossref","first-page":"6504","DOI":"10.1016\/j.vaccine.2009.07.076","article-title":"A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra): immunogenicity and safety profile","volume":"27","author":"Czajka","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0200","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0264-410X(02)00459-0","article-title":"Reactogenicity and immunogenicity of a live attenuated tetravalent measles\u2013mumps\u2013rubella\u2013varicella (MMRV) vaccine","volume":"21","author":"Nolan","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.05.015_bib0205","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10654-008-9306-7","article-title":"SMS versus telephone interviews for epidemiological data collection: feasibility study estimating influenza vaccination coverage in the Swedish population","volume":"24","author":"Bexelius","year":"2009","journal-title":"Eur J Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.05.015_bib0210","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16302985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T22:44:31Z","timestamp":1600555471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16302985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":21,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0264410X16302985"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous active surveillance of adverse events following immunisation using SMS technology","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}